The Rockefeller University
COVID-19: Where Are We Now and Where Are We Headed?
updated
25th Anniversary Women & Science Lecture and Luncheon
Unlocking the Science of Memory
May 12, 2022
SPEAKER
Priya Rajasethupathy, M.D., Ph.D.
Jonathan M. Nelson Family Assistant Professor
Laboratory of Neural Dynamics and Cognition
The Rockefeller University
HOST
Richard P. Lifton, M.D., Ph.D.
President and Carson Family Professor
Laboratory of Human Genetics and Genomics
Rockefeller neuroscientist Priya Rajasethupathy develops and applies sophisticated technologies to explore the genes, cells, and neural circuits that orchestrate the dynamics of memory. In recent years, her discoveries have challenged conventional notions of how memories are stored and retrieved. Research by Dr. Rajasethupathy and colleagues has shown, for example, how memory function involves parts of the brain that had not previously been thought to play a role.
Many of us take memory for granted until we see how disruptions associated with conditions such as Alzheimer’s disease, post-traumatic stress disorder, or drug addiction profoundly diminish our quality of life, or even threaten survival. By revealing the mechanisms that underlie this essential cognitive process, work by Dr. Rajasethupathy is helping to elucidate how memory is compromised by neurodegeneration or other impairments. Recently, she has also begun to search for therapeutics that can modulate the brain’s memory systems when improvement is needed.
Dr. Rajasethupathy joined the Rockefeller faculty in 2017. She had previously conducted postdoctoral research at Stanford with Dr. Karl Deisseroth, after earning M.D. and Ph.D. degrees at Columbia, where she worked with Nobel laureate Eric Kandel. Dr. Rajasethupathy is the recipient of numerous honors, including a National Institutes of Health Director’s New Innovator Award, a Presidential Early Career Award for Scientists and Engineers, and a Klingenstein-Simons Fellowship, among many others.
For more information on Women & Science, please visit our website: https://www.rockefeller.edu/support-our-science/women-and-science/
April 27, 2023
SPEAKERS
Erich D. Jarvis, Ph.D.
Professor, Laboratory of Neurogenetics of Language
The Rockefeller University
Investigator, Howard Hughes Medical Institute
Constantina Theofanopoulou, Ph.D.
Associate Research Professor
Hunter College, City University of New York
HOST
Richard P. Lifton, M.D., Ph.D.
President and Carson Family Professor
Laboratory of Human Genetics and Genomics
The Rockefeller University
Dancing and singing are perhaps the most ancient forms of human expression. For Erich Jarvis, a neuroscientist who trained professionally in ballet, it was not entirely surprising to discover that neural circuits enabling us to learn movements are in close proximity to parts of the brain essential to speech. Dr. Jarvis studies songbirds and other animals to identify genes and brain centers that underlie vocal learning. His work is helping to explain how the human brain evolved to produce complex spoken language.
Like Dr. Jarvis, Constantina Theofanopoulou is a neuroscientist as well as an accomplished flamenco dancer. Drawing on the latest findings from many convergent lines of research, Dr. Jarvis and Dr. Theofanopoulou will provide a fascinating look into the genes-to-neurons choreography that connects with motor systems to enable us to sing and dance. They will also discuss movement and speech disorders that stem from disruptions in these neural pathways, as well as the roles that music and dance can play in the treatment of conditions such as Parkinson’s disease and autism.
The Rockefeller University awards its 2023 Lewis Thomas Prize for Writing About Science to forest ecologist and author Dr. Suzanne Simard. The Prize, given annually by The Rockefeller University, recognizes Dr. Simard for her research which spurred the field of mycorrhizal networks and her best selling book, "Finding the Mother Tree: Discovering the Wisdom of the Forest." Hosted by President Richard P. Lifton on Monday, April 17, 2023.
2022 Fall Morning Lecture
New Insights into Rheumatoid Arthritis: How Self-Testing Could Revolutionize the Fight Against Autoimmune Diseases
Speaker:
Dana Orange, M.D., M.Sc.
Assistant Professor of Clinical Investigation
The Rockefeller University
Assistant Attending Rheumatologist
Hospital for Special Surgery
Host:
Sarah Schlesinger, M.D.
Senior Attending Physician, Rockefeller University Hospital
Associate Professor of Clinical Investigation
Laboratory of Chemical Biology and Signal Transduction
The Rockefeller University
More than 1.3 million people in the U.S. suffer from rheumatoid arthritis, an autoimmune disease that causes inflammation, debilitating pain, and irreversible joint damage, among other symptoms. Notably, women are twice as likely as men to develop rheumatoid arthritis and other autoimmune conditions. What are the factors that lead to this prevalence in women? And how can we better predict and prevent flare-ups in arthritis and other inflammatory disorders?
Dana Orange, M.D., M.Sc., seeks to answers these questions by focusing on the pathogenic mechanisms that cause rheumatoid arthritis. Working with Robert Darnell, M.D., Ph.D., at Rockefeller, Dr. Orange developed a novel testing system that made it possible to monitor cellular and molecular changes in rheumatoid arthritis patients in unprecedented detail. Her unique approach led to the discovery of a new cell type—called a PRIME cell—that may prove to be a reliable marker for impending rheumatoid arthritis flares, as well as a promising new therapeutic target.
Dr. Orange earned an M.D. with honors from Weill Cornell Medical College and a master’s in translational research at Rockefeller University as a Beth and Ravenel Curry Clinical Scholar. She completed an internal medicine residency at New York-Presbyterian Hospital and a rheumatology fellowship at the Hospital for Special Surgery.
Learn more about Rockefeller's Women & Science initiative at https://www.rockefeller.edu/support-our-science/women-and-science
April 21, 2022
SPEAKER
Holly S. Andersen, M.D.
Attending Cardiologist, Associate Professor of Medicine
Director of Education & Outreach, The Ronald O. Perelman Heart Institute
NewYork-Presbyterian Hospital / Weill Cornell Medical Center
Trustee, The Rockefeller University
HOST
Richard P. Lifton, M.D., Ph.D.
President and Carson Family Professor
Laboratory of Human Genetics and Genomics
The Rockefeller University
Holly S. Andersen, M.D., a distinguished cardiologist who serves as a Rockefeller University Trustee, discussed the latest scientific and medical breakthroughs in cardiovascular health and their impact on disease prevention and patient care. She also discussed the cardiovascular complications of COVID-19. An authority on preventive cardiology and an advocate for heart disease awareness, Dr. Andersen is director of education and outreach for the Ronald O. Perelman Heart Institute at Weill Cornell Medicine. She is also an attending cardiologist and associate professor of clinical medicine at the NewYork-Presbyterian Hospital, Weill Cornell Medical Center. This webinar was hosted by Rockefeller president Richard P. Lifton, M.D., Ph.D.
Portrait of Discovery: Five Rockefeller Trailblazers Who Made Scientific History
An Unveiling Celebration
On the evening of Thursday, April 14, 2022, The Rockefeller University hosted the unveiling of a new portrait of five historic scientists. The event was held in celebration of the 25th Anniversary of the Women & Science initiative.
This groundbreaking portrait—the university’s first depicting women scientists—features Drs. Marie Daly, Rebecca Lancefield, Louise Pearce, Gertrude Perlmann, and Florence Sabin, researchers who held significant tenures at Rockefeller or went on to have distinguished careers at other institutions after training at the university. All were among the first women in their respective fields and are recognized for their pioneering contributions to science.
Speakers:
HOST
Richard P. Lifton, M.D., Ph.D.
President and Carson Family Professor
The Rockefeller University
REMARKS
Audrey Harnagel
President
Women in Science at Rockefeller (WISeR)
TRIBUTES TO PORTRAIT HONOREES
Leslie B. Vosshall, Ph.D.
Robin Chemers Neustein Professor
The Rockefeller University
Vice President and Chief Scientific Officer
Howard Hughes Medical Institute
ARTIST PRESENTATION
Brenda Zlamany
Painter
This portrait was commissioned in 2020 by Women in Science at Rockefeller (WISeR) and the Women & Science Initiative with the support of generous benefactors. It now hangs in the lounge of Abby Aldrich Rockefeller Hall at Rockefeller University.
For more information, please visit: https://www.rockefeller.edu/support-our-science/women-and-science/portrait-initiative/
Women & Science Entrepreneurship Fund Speaker Series Webinar
December 2, 2021
HOST
Karen Akinsanya, Ph.D.
EVP, Chief Biomedical Scientist, and Head of R&D
Schrödinger
Rockefeller University Trustee
PANELISTS
Leigh Baxt, Ph.D.
Associate Director of Biology
Tri-Institutional Therapeutics Discovery Institute
Jeanne Farrell, Ph.D.
Associate Vice President
Office of Technology Transfer
The Rockefeller University
Jessica Hopfield, Ph.D. ’91
Healthcare Strategist and Investor
President, J Hopfield Consulting
On Thursday, December 2, 2021, Dr. Karen Akinsanya led a discussion with Dr. Leigh Baxt, Dr. Jeanne Farrell, and Dr. Jessica Hopfield about their unique perspectives within the translational ecosystem. The panelists shared their experience regarding their transition from the bench to their current positions outside of academia. The event included a Q&A with webinar participants.
The Women & Science Entrepreneurship Fund (WEF) is designed to help ensure that every Rockefeller University scientist who wants to realize the therapeutic potential of her discoveries has the tools, support, and knowledge to do so. The fund will also amplify the potential of Rockefeller’s unique translational programs to reap therapeutic rewards. The WEF Speaker Series features leaders from biotech and pharma to talk directly with Rockefeller researchers.
For more information: https://www.rockefeller.edu/support-our-science/women-and-science/ws-entrepreneurship-fund/
Women & Science Initiative
November 16, 2021
SPEAKER
Kate Jeffrey, Ph.D.
Associate Professor of Medicine
Massachusetts General Hospital, Harvard Medical School
Associate Member, Broad Institute of MIT and Harvard University
2010 Women & Science Postdoctoral Fellow, The Rockefeller University
HOST
Alexander Tarakhovsky, M.D., Ph.D.
Dr. Plutarch Papamarkou Professor
Laboratory of Immune Cell Epigenetics and Signaling
The Rockefeller University
The incidences of chronic inflammatory diseases such as allergies, arthritis, and diabetes are rising in Western societies at alarming rates, and genetics alone cannot explain this increase. In this webinar, former Rockefeller University Women & Science Fellow Kate Jeffrey, Ph.D. explores how the epigenome integrates the dynamic relationship between humans and their environment and is a possible cause and drug discovery target for these diseases of affluence and age.
Dr. Jeffrey is an associate professor of medicine at Harvard Medical School, an associate in immunology at Massachusetts General Hospital, a faculty member of immunology and virology at Harvard University, and an associate member of the Broad Institute of MIT and Harvard University. Dr. Jeffrey pursued her undergraduate studies at the University of Melbourne, Australia, and completed her Ph.D. with Professor Charles Mackay at the Garvan Institute of Medical Research in Sydney, Australia. She conducted her postdoctoral research at Rockefeller University with Alexander Tarakhovsky, M.D., Ph.D., during which time she received a Women & Science fellowship.
In 2012, she launched her independent laboratory at Massachusetts General Hospital and Harvard Medical School. She and her team now study host-pathogen interactions—work that is essential for developing therapies to improve human health. Dr. Jeffrey has also served as an immunology editor with Nature Medicine and co-founded the Imagine Science Film Festival in New York City.
Learn more about Rockefeller's Women & Science initiative at https://www.rockefeller.edu/women-and-science
Women & Science Entrepreneurship Fund Speaker Series Webinar
March 24, 2021
SPEAKER
Brandy Houser, Ph.D.
NYC Site Head, Celdara Medical
Co-Founder of Traverse Biotech, Fiddlehead Foundation, and Women Accelerators
HOST
Agata Smogorzewska, M.D., Ph.D., '02
Associate Professor, Laboratory of Genome Maintenance
The Rockefeller University
On Wednesday, March 24, 2021, Dr. Brandy Houser, a leading expert in biotechnology development and investment, shared a 30,000-foot aerial overview of the complex therapeutic discovery ecosystem. This webinar explored the challenges that women scientists may face as they contemplate breaking into the field. The event included a Q&A with webinar participants.
The Women & Science Entrepreneurship Fund (WEF) is designed to help ensure that every Rockefeller University scientist who wants to realize the therapeutic potential of her discoveries has the tools, support, and knowledge to do so. The fund will also amplify the potential of Rockefeller’s unique translational programs to reap therapeutic rewards. The WEF Speaker Series features leaders from biotech and pharma to talk directly with Rockefeller researchers.
For more information: https://www.rockefeller.edu/support-our-science/women-and-science/ws-entrepreneurship-fund/
Women & Science Spring Morning Webinar
March 10, 2021
SPEAKER
Mandë Holford, Ph.D., ‘03
Associate Professor in Chemistry
Hunter College and The CUNY Graduate Center
HOST
Vanessa Ruta, Ph.D., ‘05
Gabrielle H. Reem and Herbert J. Kayden Associate Professor
Laboratory of Neurophysiology and Behavior
The Rockefeller University
Venoms—molecules that evolved as toxins—have the power to transform lives. Marine chemical biologist Dr. Mandë Holford studies snail venom and its ability to disable prey by interfering with cell signaling. These peptides can provide insights into cellular physiology, informing efforts to develop novel therapeutics for pain disorders and cancer, new agricultural pesticides with gentler environmental impacts, and myriad other innovations yet to be discovered.
A 2003 graduate of Rockefeller, Dr. Holford is an Associate Professor of Chemistry at CUNY Hunter College and The CUNY Graduate Center. She also holds scientific appointments at the American Museum of Natural History and Weill Cornell Medicine, reflecting her interdisciplinary approach to marine biology and chemistry that ranges “from mollusks to medicine.”
Dr. Holford co-developed a premier Science Diplomacy course at Rockefeller University to encourage early career scientists to think globally about the impacts of their research. She was selected as a 2020 Sustainability Pioneer by the World Economic Forum, which named her a New Champion Young Scientist in 2015. She was recognized as a Breakthrough Woman in Science by the Howard Hughes Medical Institute and NPR’s Science Friday. She is a fellow of the California Academy of Sciences.
She is also co-founder of Killer Snails, LLC, an award winning EdTech company that uses tabletop, digital, and XR games about extreme creatures in nature as a conduit to advance scientific learning in K–12 classrooms. Dr. Holford is a Life Member of the Council of Foreign Relations and a Science & Technology Policy Fellow with the American Association for the Advancement of Science. An advocate for science education at all grade levels, she is also the recipient of a prestigious Camille Dreyfus Teacher-Scholar Award.
For more information on Women & Science, visit our website: https://www.rockefeller.edu/support-our-science/women-and-science/
October 26, 2021
SPEAKER
Daniel Mucida, Ph.D.
Professor
Laboratory of Mucosal Immunology
Investigator, Howard Hughes Medical Institute
HOST
Richard P. Lifton, M.D., Ph.D.
President and Carson Family Professor
Laboratory of Human Genetics and Genomics
In this webinar, professor Daniel Mucida investigates the delicate balance of the digestive system and its critical role in health. His research embraces multiple fields of biomedicine, revealing unexpected cellular and molecular mechanisms that underlie the so-called gut-brain axis. Dr. Mucida’s research is providing insights into the origins of many gastrointestinal pathologies, including chronic inflammatory disorders, food allergies, and colon cancer. The understanding gained from this work can inform new approaches to the prevention and treatment of these and other diseases.
Learn more about Rockefeller, Dr. Mucida's ongoing research, and support the university at https://www.rockefeller.edu/
Virtual Discussions with Genuine Experts
September 14, 2021
Speakers:
Richard P. Lifton, M.D., Ph.D.
President and Carson Family Professor
Laboratory of Human Genetics and Genomics
The Rockefeller University
Paul Bieniasz, Ph.D.
Professor
Laboratory of Retrovirology
Investigator, Howard Hughes Medical Institute
In this webinar, President Rick Lifton provides an update on the state of the COVID-19 pandemic. He is then joined by virologist Paul Bieniasz to address critical questions on the latest vaccine and variant data.
Your contributions are vital to COVID-19 research.
To learn more about research at Rockefeller University and to make a gift to the Fund for COVID-19 Research please visit: https://covid-19-research.rockefeller.edu/
The Rockefeller University awards its 2021 Lewis Thomas Prize for Writing about Science to ornithologist, scientist, and author Dr. Richard O. Prum. The award, given annually by The Rockefeller University, recognizes Dr. Prum’s visionary research along with his vivid and compelling writing for all audiences. The prize presentation is followed by a lecture by Dr. Prum and a conversation with Dr. Erich D. Jarvis, Professor at The Rockefeller University.
April 13, 2021
HOST
Richard P. Lifton, M.D., Ph.D.
President and Carson Family Professor
Laboratory of Human Genetics and Genomics
The Rockefeller University
SPEAKER
Barry S. Coller, M.D.
Physician in Chief, The Rockefeller University Hospital
David Rockefeller Professor
Allen and Frances Adler Laboratory of Blood and Vascular Biology
The Rockefeller University
The odd of surviving a heart attack have improved dramatically, thanks to a range of interventions available in hospitals equipped for coronary care. The weak link in the treatment chain is time: early treatment is crucial in preventing irreversible damage to the heart, but it is difficult to administer before patients reach the hospital.
Barry S. Coller, M.D. is working to prevent deaths by treating patients during the critical pre-hospital period. He has created a small molecule, RUC-4 (generic name zalunfiban), that prevents blood platelets from sticking together. Platelets sticking together initiates the blood clots that cause heart attacks. Crucially, RUC-4 is designed to be administered in the ambulance or even self-administered via a simple injection device. Dr. Coller discusses this potential drug’s development and the promising results from early clinical trials.
Learn more about Rockefeller, Dr. Coller’s ongoing research, and support the university at https://www.rockefeller.edu/


